Company: EDSA
Filing Date: 2025-07-25
Form Type: S-3
Source: 0001171843-25-004721
Chunk: 17

Company: Edesa Biotech, Inc.
Filing Date: 2025-07-25
Form: S-3
Chunk 17
---
 and its telephone number is 1-604-661-9400.

Listing on The Nasdaq Capital Market

Our common shares are listed on the Nasdaq Capital Market under the symbol “EDSA.”

| 11 |

<div align='center'>DESCRIPTION OF WARRANTS</div>

We summarize below some of the provisions that will apply to the warrants unless the applicable prospectus supplement provides otherwise. This summary may not contain all information that is important to you. The complete terms of the warrants will be contained in the applicable warrant certificate and warrant agreement. These documents have been or will be included or incorporated by reference as exhibits to the registration statement of which this prospectus is a part. You should read the warrant certificate and the warrant agreement. You should also read the prospectus supplement, which will contain additional information and which may update or change some of the information below.

General

We may issue warrants to purchase our debt or equity securities or securities of third parties or other rights, including rights to receive payment in cash or securities based on the value, rate or price of one or more specified commodities, currencies, securities or indices, or any combination of the foregoing. Warrants may be issued independently or together with any other securities and may be attached to, or separate from, such securities. Each series of warrants will be issued under a separate warrant agreement to be entered into between us and a bank, trust company or other financial institution, as warrant agent, or we may issue warrants directly to investors. A description of the terms and material provisions of any warrants we may issue will be set forth in the applicable prospectus supplement.

The applicable prospectus supplement will describe the following terms of any warrants in respect of which this prospectus is being delivered:

| · | the title of such warrants; |

| · | the aggregate number of such warrants; |

| · | the price or prices at which such warrants will be issued; |

| · | the currency or currencies in which the price of such warrants will be payable; |

| · | the securities or other rights, including rights to receive payment in cash or securities based on the                                         
 value, rate or price of one or more specified commodities, currencies, securities or indices, or any combination of the foregoing, purchasable 
 upon exercise of such warrants;                                                                                                                |

| · | the price at which and the currency or currencies in which the securities or other rights purchasable upon 
 exercise of such warrants may be purchased;                                                                |

| · | the date on which the right to exercise such